- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-06-0001311

About SLB Pharma Private Limited
Data last updated:
SLB Pharma Private Limited is a private limited company based in Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 March 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2007PTC053031. Its GSTIN is 36AAMCS3891E1Z0 (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹1.35 Cr. It was formerly known as Sri Lakshmi Bhargavi Pharma Private Limited. It is led by directors including Narendra Babu Kantipudi and Gurram Subbalakshmi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 GF & 3 4 5 Ff Sdf Block – 2 Epip Pashamylaram (V), Telangana, India – 502307.
As per the financials filed for FY 2025, the company reported a revenue of ₹13.1 Cr, a growth of 78% compared to the previous year. For the same year it recorded a net profit of ₹1.37 Cr (net margin 10.5%) and EBITDA of ₹2.33 Cr (EBITDA margin 17.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 16% over five years.
The company has about 15 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹4.26 Cr on record.
SLB Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-06-0001311). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website srilbpharma.com.
Company details
CIN history
SLB Pharma has one previous CIN (Corporate Identification Number): U24232AP2007PTC053031. The current CIN is U24232TG2007PTC053031, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2007PTC053031 | Current |
| U24232AP2007PTC053031 | Previous |
Recognitions & Rankings of SLB Pharma
Contact details
SLB Pharma Private Limited's registered office is in Telangana. Its website is srilbpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address3 GF & 3 4 5 Ff Sdf Block – 2 Epip Pashamylaram (V), Telangana, India – 502307
- IndustryPharma, Drug Formulation & Development
To see the full contact details of SLB Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of SLB Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of SLB Pharma Private Limited, buy the company report.
Financials of SLB Pharma Private Limited
FY 2025 filings availableSLB Pharma Private Limited reported revenue of ₹13.1 Cr (up 78% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 16% over five years, including 78% growth in the latest year. EBITDA rose 125% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.33 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.37 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.8% | ||||
| Net Profit Margin | 10.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of SLB Pharma Private Limited, buy the company report.
Board of directors of SLB Pharma Private Limited
SLB Pharma has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Babu Kantipudi | Director | 15 Nov 2008 | 17 Years 11 Months | Current |
| Gurram Subbalakshmi Also directs: Haritha Laboratories Private Limited | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Debashish Datta | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
| Vundavalli Nagavara Prasad Also directs: Vundavalli Enterprises Private Limited | Director | 08 Jun 2015 | 11 Years 5 Months | Current |
| Mohanaiah Paladi Also directs: NSL Krishnaveni Sugars Limited, Mandava Holdings Private Limited, Access Livelihoods Consulting India Limited and 2 more | Director | 10 Aug 2020 | 6 Years 2 Months | Current |
Peer comparison
SLB Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genees Pharmaceutical Private Limited | ₹13.26 Cr (FY 2025) | 27.0% | Pune, Maharashtra, India | |||
| Zinnia Life Sciences Private Limited | ₹13.25 Cr (FY 2025) | 74.0% | Coimbatore, Tamil Nadu, India | |||
| SLB Pharma Private Limitedthis company | ₹13.1 Cr (FY 2025) | ₹1.37 Cr | 10.5% | 78.0% | 15 | Telangana, India |
| Meddoxx Pharmaceuticals Private Limited | ₹13.03 Cr (FY 2025) | 14.0% | Kozhikode, Kerala, India | |||
| Aster Medicines Private Limited | ₹13 Cr (FY 2025) | 20.0% | Patna, Bihar, India | |||
| Middle Mist Pharmaceuticals Private Limited | ₹12.96 Cr (FY 2025) | -6.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of SLB Pharma Private Limited, buy the company report.
Auditor
SLB Pharma Private Limited is audited by A.S.R.V Prasad & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.S.R.V Prasad & Co | FY 2023 | 009983S |
Shareholding
The shareholding of SLB Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of SLB Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 May 2024 | 100909391 | Bank of India | ₹2 Cr | Open | |
| 03 Jan 2024 | 100839072 | Bank of India | ₹19 Lakh | Open | |
| 03 Jan 2024 | 100839074 | Bank of India | ₹10 Lakh | Open | |
| 06 May 2010 | 10294848 | Bank of India | ₹1.97 Cr | Open |
To see the full charge records of SLB Pharma Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving SLB Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for SLB Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
SLB Pharma Private Limited has a workforce of 15 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
SLB Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAMCS3891E1Z0 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of SLB Pharma Private Limited, buy the company report.
Recent activity
SLB Pharma Private Limited has 9 board changes on record since 2008: 5 appointments and 4 cessations. The latest: Dasari Sreenivasulu ceased to be Director on 19 Nov 2020.
5 earlier events are in the company report.
Frequently asked questions
SLB Pharma is an active private limited company based in Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 March 2007 (19+ years old) and is registered under CIN U24232TG2007PTC053031.
SLB Pharma has 5 current directors:
- Narendra Babu Kantipudi - Director
- Gurram Subbalakshmi - Director
- Debashish Datta - Director
- Vundavalli Nagavara Prasad - Director
- Mohanaiah Paladi - Director
The latest financial statements of SLB Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of SLB Pharma is 36AAMCS3891E1Z0, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of SLB Pharma is U24232TG2007PTC053031. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
SLB Pharma was incorporated on 05 March 2007, making it 19+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of SLB Pharma by revenue are Genees Pharmaceutical Private Limited, Zinnia Life Sciences Private Limited, Meddoxx Pharmaceuticals Private Limited, Aster Medicines Private Limited, Middle Mist Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dasari Sreenivasulu ceased to be Director on 19 Nov 2020. Debashish Datta was appointed as Director on 10 Aug 2020. Gurram Subbalakshmi was appointed as Director on 10 Aug 2020. SLB Pharma has 9 board changes on record in total.
Yes, SLB Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-06-0001311).
SLB Pharma can be reached through the website srilbpharma.com. Its registered office is in Telangana, India.
The registered office of SLB Pharma is at 3 GF & 3 4 5 Ff Sdf Block – 2 Epip Pashamylaram V, Telangana, India – 502307.

